Retagliptin Phosphate | m-entrepreneurship.com

Product Name :
Retagliptin Phosphate

Search keywords :
Retagliptin

drugId :
null

Target Vo:
Dipeptidyl peptidase IV

Target Vo Short Name :
DPP4

Moa_Name:
Dipeptidyl peptidase IV inhibitors

First Approval Country :
Mainland China

First Approval Date Filter:
2023

Origin Company_Name :
Jiangsu Hengrui Medicine Co Ltd

Active Company_Name :
Jiangsu Hengrui Medicine Co Ltd

Active Indication_Name:
Diabetes Mellitus, Type 2

In Active Indication_Name:
Renal Insufficiency

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Minretumomab In Vitro
PKC beta 2 Rabbit mAb Protocol
Pan-Actin Antibody: Pan-Actin Antibody is a non-conjugated and Mouse origined monoclonal antibody about 42kDa, targeting to Pan-Actin. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts